Showing results (391-400 of 414) with videos related to

Sort By:
Pageof 42
The Journal of Clinical Investigation|July 15, 2020
A coagulation defect arising from heterozygous premature termination of tissue factorSol Schulman, Emale El-Darzi, Mary Hc Florido, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2016
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 AntibodyUrsula Jördis Eva Seidel, Patrick Schlegel, Ludger Grosse-Hovest, et al.
Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.
Blood|May 24, 2014
Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapyChristian Stemberger, Patricia Graef, Marcus Odendahl, et al.
Leukemia Research|October 17, 2013
The clinical significance of cereblon expression in multiple myelomaSteven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Blood|December 29, 2025
Brentuximab Vedotin and Nivolumab in Combination With Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin LymphomaJeremy S Abramson, David J Straus, Nancy L Bartlett, et al.
Bone Marrow Transplantation|October 30, 2012
Allo-SCT using BU, CY and melphalan for children with AML in second CRR Beier, M H Albert, P Bader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II TrialTim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2025
Optimizing participant and community engagement in cancer genomic sequencing researchNorah L Crossnohere, Anne L R Schuster, Cindy K Blair, et al.
Bone Marrow Transplantation|May 16, 2019
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALLFlorian Babor, Christina Peters, Angela R Manser, et al.
Pageof 42